These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27679539)

  • 1. (18)F-fluorodeoxyglucose and (18)F-flumazenil positron emission tomography in patients with refractory epilepsy.
    Hodolic M; Topakian R; Pichler R
    Radiol Oncol; 2016 Sep; 50(3):247-53. PubMed ID: 27679539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronuclear assessment of patients with epilepsy.
    Goffin K; Dedeurwaerdere S; Van Laere K; Van Paesschen W
    Semin Nucl Med; 2008 Jul; 38(4):227-39. PubMed ID: 18514079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography in presurgical localization of epileptic foci.
    Csaba J
    Ideggyogy Sz; 2003 Jul; 56(7-8):249-54. PubMed ID: 12971120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients.
    Ryvlin P; Bouvard S; Le Bars D; De Lamérie G; Grégoire MC; Kahane P; Froment JC; Mauguière F
    Brain; 1998 Nov; 121 ( Pt 11)():2067-81. PubMed ID: 9827767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial EEG versus flumazenil and glucose PET in children with extratemporal lobe epilepsy.
    Muzik O; da Silva EA; Juhasz C; Chugani DC; Shah J; Nagy F; Canady A; von Stockhausen HM; Herholz K; Gates J; Frost M; Ritter F; Watson C; Chugani HT
    Neurology; 2000 Jan; 54(1):171-9. PubMed ID: 10636144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy.
    Juhász C; Chugani DC; Muzik O; Watson C; Shah J; Shah A; Chugani HT
    Neurology; 2000 Sep; 55(6):825-35. PubMed ID: 10994004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.
    Vivash L; Gregoire MC; Lau EW; Ware RE; Binns D; Roselt P; Bouilleret V; Myers DE; Cook MJ; Hicks RJ; O'Brien TJ
    J Nucl Med; 2013 Aug; 54(8):1270-7. PubMed ID: 23857513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imaging Analysis.
    Komoto D; Iida K; Higaki T; Kaichi Y; Takauchi K; Arihiro K; Kakita A; Hirokawa Y; Awai K
    Hiroshima J Med Sci; 2015 Dec; 64(4):51-7. PubMed ID: 26964154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of 11C-flumazenil positron emission tomography in intractable temporal lobe epilepsy.
    Padma MV; Simkins R; White P; Satter M; Christian BT; Dunigan K; Lee C; Jacobs M; Mukherjee J; Mantil JC
    Neurol India; 2004 Dec; 52(4):457-62. PubMed ID: 15626833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of PET imaging for the localization of epileptogenic zone in patients with epilepsy: a meta-analysis.
    Niu N; Xing H; Wu M; Ma Y; Liu Y; Ba J; Zhu S; Li F; Huo L
    Eur Radiol; 2021 Aug; 31(8):6353-6366. PubMed ID: 33523306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and [11C]flumazenil positron emission tomography abnormalities of thalamic nuclei in temporal lobe epilepsy.
    Juhász C; Nagy F; Watson C; da Silva EA; Muzik O; Chugani DC; Shah J; Chugani HT
    Neurology; 1999 Dec; 53(9):2037-45. PubMed ID: 10599778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is 11C-flumazenil PET superior to 18FDG PET and 123I-iomazenil SPECT in presurgical evaluation of temporal lobe epilepsy?
    Debets RM; Sadzot B; van Isselt JW; Brekelmans GJ; Meiners LC; van Huffelen AO; Franck G; van Veelen CW
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):141-50. PubMed ID: 9048714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome.
    Juhász C; Chugani DC; Muzik O; Shah A; Shah J; Watson C; Canady A; Chugani HT
    Neurology; 2001 Jun; 56(12):1650-8. PubMed ID: 11425929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Functional imaging (PET and SPECT) in epilepsy].
    Borbély K
    Orv Hetil; 2001 Nov; 142(44):2405-14. PubMed ID: 11766233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfusion SPECT, SISCOM and PET (18)F-FDG in the assessment of drug- refractory epilepsy patients candidates for epilepsy surgery.
    Suárez-Piñera M; Mestre-Fusco A; Ley M; González S; Medrano S; Principe A; Mojal S; Conesa G; Rocamora R
    Rev Esp Med Nucl Imagen Mol; 2015; 34(6):350-7. PubMed ID: 26118354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MRI-guided flumazenil- and FDG-PET in temporal lobe epilepsy.
    Szelies B; Weber-Luxenburger G; Pawlik G; Kessler J; Holthoff V; Mielke R; Herholz K; Bauer B; Wienhard K; Heiss WD
    Neuroimage; 1996 Apr; 3(2):109-18. PubMed ID: 9345482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced [(18)F]FDG and [(11)C]flumazenil PET analysis for individual outcome prediction after temporal lobe epilepsy surgery for hippocampal sclerosis.
    Yankam Njiwa J; Gray KR; Costes N; Mauguiere F; Ryvlin P; Hammers A
    Neuroimage Clin; 2015; 7():122-31. PubMed ID: 25610774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of localization accuracy and postsurgical prediction of simultaneous
    Guo K; Cui B; Shang K; Hou Y; Fan X; Yang H; Zhao G; Lu J
    Eur Radiol; 2021 Sep; 31(9):6974-6982. PubMed ID: 33638688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interictal and postictal
    Carvalho MS; Alvim MKM; Etchebehere E; Santos AO; Ramos CD; Argenton JLP; Cendes F; Amorim BJ
    Radiol Bras; 2022; 55(5):273-279. PubMed ID: 36320375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.